Biotech News
iSpecimen Names Tracy Curley as Chief Executive Officer
Previously Appointed Interim CEO in September 2022
LEXINGTON, Mass., Jan. 10, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc....
Open original release
Related news
ISPCiSpecimen2026-06-25 13:46 EST
iSpecimen to Participate in the ThinkEquity Conference on October 26, 2022
ISPCiSpecimen2026-06-25 13:46 EST
iSpecimen to Report Third Quarter 2022 Results on November 8, 2022
ISPCiSpecimen2026-06-25 13:46 EST
iSpecimen Launches New Open Feasibilities Dashboard on the iSpecimen Marketplace Platform to Enhance Biospecimen Fulfillment for Global Partner Network
ISPCiSpecimen2026-06-25 13:46 EST
iSpecimen Reports Third Quarter 2022 Financial and Operating Results
ISPCiSpecimen2026-06-25 13:46 EST
iSpecimen Appoints Joseph J. Basile to Board of Directors
ISPCiSpecimen2026-06-25 13:46 EST
iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on January 25, 2023
ISPCiSpecimen2026-06-25 13:46 EST
iSpecimen to Participate in the Sequire Biotechnology Conference on February 2, 2023
ISPCiSpecimen2026-06-25 13:46 EST
iSpecimen Appoints Eric Langlois as Chief Revenue Officer
ISPCiSpecimen2026-06-25 13:46 EST
iSpecimen Expands Biospecimen Provider Network
ISPCiSpecimen2026-06-25 13:46 EST
iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023
iSpecimen
iSpecimen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Recent company news
ISPCiSpecimen2026-06-26 10:40 EST
iSpecimen to Participate in the ThinkEquity Conference on October 26, 2022
ISPCiSpecimen2026-06-26 10:40 EST
iSpecimen to Report Third Quarter 2022 Results on November 8, 2022
ISPCiSpecimen2026-06-26 10:40 EST
iSpecimen Launches New Open Feasibilities Dashboard on the iSpecimen Marketplace Platform to Enhance Biospecimen Fulfillment for Global Partner Network
ISPCiSpecimen2026-06-26 10:40 EST
iSpecimen Reports Third Quarter 2022 Financial and Operating Results
ISPCiSpecimen2026-06-26 10:40 EST
iSpecimen Appoints Joseph J. Basile to Board of Directors
Stock data
- Close
- —
- Market cap
- —
- Exchange
- NASDAQ
- Sector
- Biotechnology
- Location
- United States